Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityNo recent work listed

Hongfei Tong

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5012588535. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
18
Papers, trials and grants by year

2011: 1 paper · 2012: 3 papers · 2013: 2 papers · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers

Papers 11

  1. Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway. Co-author DOI 10.2147/ott.s253691↗
  2. Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells. Co-author DOI 10.3892/ijo.2020.4956↗
  3. Emodin sensitizes human pancreatic cancer cells to EGFR inhibitor through suppressing Stat3 signaling pathway. Last author DOI 10.2147/cmar.s221877↗
  4. Emodin inhibits angiogenesis in pancreatic cancer by regulating the transforming growth factor-β/drosophila mothers against decapentaplegic pathway and angioge… Last author DOI 10.3892/mmr.2015.4158↗
  5. Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE‑cadherin/EphA2/MMP9/MMP2 expression. Co-author DOI 10.3892/ijo.2014.2500↗
  6. Involvement of endoplasmic reticulum stress in capsaicin-induced apoptosis of human pancreatic cancer cells. Last author DOI 10.1155/2013/629750↗
  7. Antiangiogenic effects of oxymatrine on pancreatic cancer by inhibition of the NF-κB-mediated VEGF signaling pathway. Co-author DOI 10.3892/or.2013.2529↗
  8. Antitumor activity of emodin against pancreatic cancer depends on its dual role: promotion of apoptosis and suppression of angiogenesis. Co-author DOI 10.1371/journal.pone.0042146↗
  9. Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro. Co-author DOI 10.3892/ijo.2011.1285↗
  10. Enhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K/Akt pathway. Co-author DOI 10.7150/ijbs.8.1↗
  11. [Effect of emodin combined gemcitabine on the growth and apoptosis of pancreatic cancer cell line BxPC-3 in vitro]. Last author PMID 21608232↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhaohong Wang · 9 shared papers, 2012–2020 · strength 0.57
  2. Zhong Hong · 2 shared papers, 2019–2020 · strength 0.22
  3. Sheng‐Zhang Lin · 4 shared papers, 2012–2015 · strength 0.14
  4. Hui Chen · 1 shared paper, 2020 · strength 0.11
  5. Muhammad Babar Jamshed · 1 shared paper, 2020 · strength 0.11
  6. Qiyu Zhang · 1 shared paper, 2020 · strength 0.11
  7. Qiyu Zhang · 1 shared paper, 2019 · strength 0.11
  8. Shengzhang Lin · 3 shared papers, 2012–2014 · strength 0.11
  9. Heqi Bu · 3 shared papers, 2012–2013 · strength 0.10
  10. Dian-Lei Liu · 3 shared papers, 2012 · strength 0.09
  11. Hongchun Guo · 3 shared papers, 2012 · strength 0.09
  12. Jing-Qiang Guo · 2 shared papers, 2014–2015 · strength 0.09
  13. Hui Chen · 2 shared papers, 2013–2014 · strength 0.08
  14. Weitian Wei · 2 shared papers, 2012 · strength 0.06
  15. Yong Zeng · 1 shared paper, 2011 · strength 0.04
  16. Liang Chen · 1 shared paper, 2014 · strength 0.04
  17. Jianhong Zhang · 1 shared paper, 2013 · strength 0.03
  18. Jian-Hong Zhang · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.